D-0424-2017 Class III Terminated
FDA drug recall D-0424-2017 was initiated by Pfizer Inc. on Sep 9, 2016 and is designated Class III. Reason for recall: Failed Impurities/Degradations Specifications; Out of specification results for two known degradation products and total impurities at 18 months The recall status is terminated (terminated Aug 18, 2017). Affected quantity: 1,706 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 18, 2017
- Initiation Date
- Sep 9, 2016
- Termination Date
- Aug 18, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,706 cartons
Product description
Cytotec (misoprostol) Tablets, 200 mcg, 100 Tablets blister pack (10X10), For in-institution use only, Rx only, Distributed by G.D. Searle, Division of Pfizer, Inc., NY, NY --- NDC 0025-1461-34
Reason for recall
Failed Impurities/Degradations Specifications; Out of specification results for two known degradation products and total impurities at 18 months
Distribution pattern
Nationwide
Code information
1) Lot # B08493 - Expiration Date 12/2016; 2) Lot # B13230 - Expiration Date 08/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0424-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026